← Back to Clinical Trials
Recruiting NCT06158880

NCT06158880 Alcohol & Men's Sexual Risk Behaviors

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06158880
Status Recruiting
Phase
Sponsor Arizona State University
Condition Sexual Behavior
Study Type INTERVENTIONAL
Enrollment 320 participants
Start Date 2024-06-17
Primary Completion 2027-12

Eligibility & Interventions

Sex Male only
Min Age 21 Years
Max Age 30 Years
Study Type INTERVENTIONAL
Interventions
Alcoholic BeverageNon-alcoholic BeveragePartner Negative Mood Manipulation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 320 participants in total. It began in 2024-06-17 with a primary completion date of 2027-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This project extends the investigators' previous research regarding the intersecting risks of alcohol, sexual risk behavior (SRB), and sexual aggression (SA) in male drinkers who have sex with women by examining the mediating and moderating roles of both intrapersonal and interpersonal emotional factors. While independent streams of research consistently document alcohol's role in SRB and SA, the investigators' work has demonstrated that these behaviors are related, and that alcohol exacerbates their likelihood both independently and synergistically. The researchers' investigations focus on a particular type of SRB: men's resistance to condom use with female partners who want to have protected sex. Condom use resistance (CUR) is common and normative among young male drinkers, with up to 80% of men reporting engaging in CUR. Of particular concern, research demonstrates that up to 42% of men report using coercive CUR tactics such as emotional manipulation, deception, condom sabotage, and force to obtain unprotected sex. Investigators will evaluate hypotheses that distal and proximal emotional and alcohol factors influence in-the-moment SRB/CUR intentions as well as daily alcohol use and SRB/CUR. The investigators will also examine whether the relationships among assessed variables are similar across experimental and naturalistic settings. That is, investigate the extent to which men's responses in the lab parallel their real-world drinking and SRB/CUR behaviors, particularly regarding self and partner emotions, empathy, and interpersonal stress.

Eligibility Criteria

Inclusion Criteria: * Single * Male * Ages 21-30 * Engagement in unprotected intercourse with a woman at least once in the past year * Consumed alcohol at least 1 time per week in the past 30 days * Had sex with a woman at least 2 times in the past 30 days Exclusion Criteria: * A history of alcohol problems * A medical condition and/or medications which contraindicate alcohol consumption * In a relationship that is monogamous and has lasted longer than 6 months

Contact & Investigator

Central Contact

Kelly Davis, PhD

✉ Kelly.Cue.Davis@asu.edu

📞 6024963217

Principal Investigator

Kelly Davis, PhD

PRINCIPAL INVESTIGATOR

Arizona State University

Frequently Asked Questions

Who can join the NCT06158880 clinical trial?

This trial is open to male participants only, aged 21 Years or older, up to 30 Years, studying Sexual Behavior. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06158880 currently recruiting?

Yes, NCT06158880 is actively recruiting participants. Contact the research team at Kelly.Cue.Davis@asu.edu for enrollment information.

Where is the NCT06158880 trial being conducted?

This trial is being conducted at Phoenix, United States.

Who is sponsoring the NCT06158880 clinical trial?

NCT06158880 is sponsored by Arizona State University. The principal investigator is Kelly Davis, PhD at Arizona State University. The trial plans to enroll 320 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology